Ann: FDA Clearance for O2Vent Optima Oral Device, page-21

People may have forgotten the deals OVN has,
As they were waiting for FDA Approval:

Brisbane, Australia 15 August 2019:

Oventus Medical Ltd or the Company (ASX: OVN) is pleased to announce it has signed further material agreements with US sleep medicine groups,
Delaware Sleep Disorder Centres and Reliable Respiratory.

The two companies will adopt the Company’s O2Vent® Sleep Treatment Platform and ‘lab in lab’ business model for the treatment of obstructive sleep apnoea (OSA) across a total of 10 facilities
divided between the two companies.

Delaware Sleep Disorder Centres is a leading sleep diagnosis and treatment group based in Newark, Delaware, in the US. Reliable Respiratory is a leading independently owned home respiratory and specialty medical equipment provider based in Massachusetts, in the US.


Under the agreements, Oventus is the exclusive supplier of dental sleep services for the treatment of OSA. The agreements initially cover 10 new sites:
three sites in Delaware with Delaware Sleep Disorder Centres,
and seven sites in New England.
A minimum monthly quota of 20 O2Vent® devices will be delivered to patients per site.

The agreements will be officially launched as soon as the O2Vent® Optima oral device has received regulatory clearance from the US FDA (application pending approval) which Oventus expects to receive in 2H calendar 2019

.............................................................................................................................................................................

So that's 200 Sales Instantly,
when FDA Approved O2 Vent...

Many more Deals will follow...